-
Mashup Score: 0
Patients with a negative colonoscopy result had a “persistently lower” risk of colorectal cancer incidence and death for at least 20 years, researchers found.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Participation in FIT-Based CRC Screening for Multiple Rounds Increases, Detection Decreases - Oncology Nurse Advisor - 26 day(s) ago
Researchers sought to determine trends in participation and detection of CRC in multiround FIT-based CRC screening.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Participation in #colorectalCancer screening using FIT may increase over multiple rounds, while detection rates for advanced colorectal neoplasms may gradually diminish with repeated screenings. https://t.co/cBcImQJlaA #CRC
-
-
Mashup Score: 0Disparities Persist in CRC Screening, Management Between High-, Low-Income Countries - 2 month(s) ago
Low- and high-income countries had significant disparities in screening for colorectal cancer (CRC) due to limited access to screening and treatment in low-income countries.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet-
A recent study found that limited access to screening & treatment remains a primary reason behind screening disparities for #colorectalcancer ( #CRC ) in low- and middle-income countries (LMICs) compared with high-income countries (HICs). Learn more here: https://t.co/oeDaSYQtTD https://t.co/vDaALMduZm
-
-
Mashup Score: 0FDA Approves Blood-Based Test for Colorectal Cancer Screening - Oncology Nurse Advisor - 3 month(s) ago
The Shield blood test for colorectal cancer screening is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Blood Collection Kit.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The U.S. Food and Drug Administration has approved Guardant Health’s Shield™ blood test for #colorectalcancer screening in individuals at average risk for the disease, age 45 years or older. From @eMPR. https://t.co/HzOAL2vVTK #CRC
-
-
Mashup Score: 2Comparative Performance of Common Fecal Immunochemical Tests: A Cross-Sectional Study: Annals of Internal Medicine: Vol 0, No 0 - 4 month(s) ago
Background: Despite widespread use of fecal immunochemical tests (FITs) for colorectal cancer (CRC) screening, data to guide test selection are limited. Objective: To compare the performance characteristics of 5 commonly used FITs, using colonoscopy as the reference standard. Design: Cross-sectional study. (ClinicalTrials.gov: NCT03264898) Setting: Three U.S. academic medical centers and affiliated endoscopy units. Participants: Patients aged 50 to 85 years undergoing screening or surveillance colonoscopy. Intervention: Participants completed 5 different FITs before their colonoscopy, including 4 qualitative tests (Hemoccult ICT, Hemosure iFOB, OC-Light S FIT, QuickVue iFOB) and 1 quantitative test (OC-Auto FIT, which was run at the manufacturer’s threshold for positivity of >100 ng/mL). Measurements: The primary outcome was test performance (sensitivity and specificity) for each of the 5 FITs for advanced colorectal neoplasia (ACN), defined as advanced polyps or CRC. Positivity rates,
Source: www.acpjournals.orgCategories: General Medicine News, General HCPsTweet-
A comparative performance study of 5 commonly used fecal immunochemical tests (FIT) found substantial variations in performance characteristics between tests: https://t.co/De3J05i5NG @IowaMed #colorectalcancer #CRC
-
-
Mashup Score: 0FIT Screening Lowered Colorectal Cancer Mortality in Several Patient Populations - Oncology Nurse Advisor - 4 month(s) ago
The effect of completing at least 1 FIT screening in a 5-year period on death from CRC was analyzed across several racial and ethnic populations.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The risk of death from #colorectalCancer was significantly lower among those who completed at least 1 FIT across several patient populations. Published in @JAMANetworkOpen. https://t.co/GbFLwb2Psh #CRC
-
-
Mashup Score: 3Digestive System Cancers Increasing Faster in Patients With vs Without IBD - Oncology Nurse Advisor - 4 month(s) ago
Researchers sought to determine the risk for digestive system cancers among individuals with vs without IBD.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Among patients with inflammatory bowel disease, the incidence of #colorectalCancer continues to decrease, although the incidence of other digestive system cancers is increasing. Study in the @AmCollegeGastro and @Gastro_Advisor. https://t.co/Jw75G7fBZi #CRC
-
-
Mashup Score: 0FIT Screening Lowered Colorectal Cancer Mortality in Several Patient Populations - Oncology Nurse Advisor - 5 month(s) ago
The effect of completing at least 1 FIT screening in a 5-year period on death from CRC was analyzed across several racial and ethnic populations.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The risk of death from #colorectalCancer was significantly lower among those who completed at least 1 FIT across several patient populations. Published in @JAMANetworkOpen. https://t.co/UiZzTwk8Uh #CRC
-
-
Mashup Score: 0Starting Adjuvant Chemotherapy Over 6 Weeks Postoperation Linked to Worse DFS - Oncology Nurse Advisor - 5 month(s) ago
Researchers investigated the optimal time from CRC operation to receive adjuvant chemotherapy to determine long-term outcomes.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Starting adjuvant chemotherapy more than 6 weeks after a surgical procedure is associated with worse DFS among patients with high-risk stage II/III #colorectalCancer. Published in @JAMASurgery. https://t.co/GA3HdETT95 #CRC
-
-
Mashup Score: 0Aspirin’s Association With CRC Risk Greater Among Patients With Unhealthy Lifestyles - 5 month(s) ago
Regular aspirin use is associated with a reduction in the risk of colorectal cancer, but this association is most notable among individuals with unhealthy lifestyles, researchers found.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Regular aspirin use is associated with a reduction in the risk of #colorectalCancer, but this association is most notable among individuals with unhealthy lifestyles. Published in @JAMAOnc. https://t.co/0I6bPponKU #CRC
-
Researchers say they have found evidence to support extending the 10-year rescreening interval after a negative colonoscopy, particularly for patients with a low or intermediate risk of developing #colorectalcancer. Reported in @JAMAOnc. https://t.co/2ZbTnZtsPb #CRC